department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

City of Hope · pharmadog

PUBLIC COMPANY

City of Hope

updated 1mo ago

community read0 votes

pipeline

2

marketed

0

phase 3

0

catalysts ytd

9

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

1Phase 11Unknown

Central Memory-Enriched T Cells

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…

CHOP [cyclophosphamide + doxorubicin + vincristine + prednisolone]

Upcoming

no upcoming catalysts on record

Recent(90d)

phase 1 initiation (1) · phase 2 results (1) · grant (1)

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view City of Hope jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

mentioned in

0news items

entity-linker matched

phase 1 initiation

City of Hope — CHOP [cyclophosphamide + doxorubicin + vincristine + prednisolone] (Phase I Trial Initiation)

CHOP [cyclophosphamide + doxorubicin + vincristine + prednisolone]

phase 2 results

City of Hope — Methotrexate Teva (Phase II Trial Results)

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — Role and regulation of methylarginine effector TDRD3 in T cell immunity

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Active trials

phase1A Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CITY-FXI in Healthy Adults and Adults With FV Leiden or Prothrombin G20210A Mutationrecruitingn=128

🐶 often sniffed alongside

top 8

tagOncology2 co-mentions · 2 sources
tagAML1 co-mentions · 1 sources
drugMETHOTREXATE1 co-mentions · 1 sources
tagType 1 Diabetes1 co-mentions · 1 sources
tagType 2 Diabetes1 co-mentions · 1 sources
tagVaccine1 co-mentions · 1 sources
tagDLBCL1 co-mentions · 1 sources
tagEndocrinology & Metabolism1 co-mentions · 1 sources